Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MEDIKON INDIA PRIVATE LIMITED | Awarded | 1 | ₹3.5 L |
| 2 | Schedule 2 | MEDIKON INDIA PRIVATE LIMITED | Awarded | 1 | ₹4.2 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Jan 2025, 3:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
SEMAGLUTIDE 3MG TAB
SEMAGLUTIDE 14MG TAB
7196746
GEM/2024/B/5660126
Two Packet Bid
SEMAGLUTIDE 3MG TAB
30 days
Jammu And Kashmir; Udhampur
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
30%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| SEMAGLUTIDE 3MG TAB | UDHAMPUR | 1,320 | 30 days | |
| SEMAGLUTIDE 14MG TAB | UDHAMPUR | 1,320 | 30 days | - |
Exempted
11 Jan 2025
21 Dec 2024
11 Jan 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7196746.pdf
GEM_BID
semug_2024-11-18-12-04-41_e671a973839df62424265c216b3fb3e0.pdf
SPECIFICATION
14mg_2024-11-18-12-06-54_8d62090a7ef2296ac6150ac36b0e2cbf.pdf
SPECIFICATION
1732774636.pdf
OTHER
1732774630.pdf
OTHER
pacste_b367afd9-9c71-4eb1-96d51732774852375_MSPCCHNC.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .